ocr: 5-Year Suruzval Series Patients Stage Rate (%) Pilipshen et al90 150 Dukes' A 80 (actuarial) 107 Dukes' B 61 154 Dukes' C 40 411 Total 58 Rich et al89 39 MAC A/BI 91 (determinate) 12 MAC B2m 64 32 MAC B2m+g 56 15 MAC - B3 29 4 MAC Cl 33 7 MAC C2m 43 27 MAC C2m - +g 23 6 MAC CS 0 142 Total 44 Minsky et al91 11 MAC A 90 (actuarial) 36 MACB1 97 21 MAC B2m 64 39 MAC B2m+g 57 9 MACB3 62 11 MAC Cl 88 8 MAC C2m 50 23 MAC C2m +g 43 10 MAC C3 30 168 Total 67
